EUVIMEDEUVIMED entdecken
Open Access

A Multi‐Omics and Single‐Cell Framework Identifies ITGA1 as a Candidate Predictive Biomarker of Neoadjuvant Chemotherapy Response in Epithelial Ovarian Cancer

Xue Xu, Ruxue Yang, Lutong Fang, Min Sun, Ying Ma, Ying Zhang, Chenxin Wu iD

BioFactors · 2026

DOI: 10.1002/biof.70135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2026. Verfasst von Xue Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Biomarkers, Tumor, Ovarian Neoplasms, Integrin alpha Chains. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reliable biomarkers that predict therapeutic response remain a major unmet need in epithelial ovarian cancer (EOC), particularly for patients receiving neoadjuvant chemotherapy (NACT). Although high‐throughput multi‐omics technologies have accelerated biomarker discovery, the translation of candidate markers into clinically actionable predictors remains limited. Here, we developed an integrative multi‐omics framework combining single‐cell RNA sequencing, bulk transcriptomic profiling, and machine‐learning‐based modeling to identify biomarkers associated with chemotherapy response in EOC. Single‐cell analyses were used to delineate cellular heterogeneity and intercellular communication landscapes before and after NACT, while bulk cohorts were leveraged to validate response‐associated molecular signatures. Network‐based and pathway analyses were applied to prioritize functionally relevant candidates. We identified integrin subunit alpha 1 (ITGA1) as a response‐associated candidate with notable discriminatory performance for chemotherapy response and functional relevance in cisplatin‐resistant ovarian cancer models. ITGA1‐related signatures stratified patients by therapeutic response and were associated with immune and stress‐response pathways, extracellular matrix signaling, and altered cell–cell communication patterns. Functional experiments showed that ITGA1 knockdown restored cisplatin sensitivity and suppressed clonogenic survival, migration, adhesion, and apoptosis evasion in resistant ovarian cancer cells. Together, our study supports ITGA1 as a response‐discriminatory and functionally relevant biomarker candidate for chemotherapy response in EOC and highlights the value of integrating single‐cell and bulk multi‐omics data with machine‐learning approaches. These findings provide a translational framework for patient stratification and experimental prioritization in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ovarian EpithelialBiomarkers, TumorOvarian NeoplasmsIntegrin alpha ChainsFemaleHumansNeoadjuvant TherapyMultiomicsCell Line, TumorGene Expression Regulation, NeoplasticSingle-Cell AnalysisCisplatinDrug Resistance, NeoplasmMachine LearningSingle-Cell Gene Expression AnalysisGene Expression Profiling

Stichwörter der Autor:innen

ITGA1epithelial ovarian cancermachine learningmulti‐omics integrationneoadjuvant chemotherapypredictive biomarkersingle‐cell RNA sequencingtumor microenvironment

Substanzen

Biomarkers, TumorCisplatinIntegrin alpha Chains

Autor:innen und Institutionen

  • Department of Pathology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
  • Department of Oncology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei, Anhui Province, China.

ORCID-Profile: Chenxin Wu

Zitieren

APA

Xu, X., Yang, R., Fang, L., Sun, M., Ma, Y., Zhang, Y., & Wu, C. (2026). A Multi‐Omics and Single‐Cell Framework Identifies ITGA1 as a Candidate Predictive Biomarker of Neoadjuvant Chemotherapy Response in Epithelial Ovarian Cancer. BioFactors. https://doi.org/10.1002/biof.70135

Vancouver

Xu X, Yang R, Fang L, Sun M, Ma Y, Zhang Y, et al. A Multi‐Omics and Single‐Cell Framework Identifies ITGA1 as a Candidate Predictive Biomarker of Neoadjuvant Chemotherapy Response in Epithelial Ovarian Cancer. BioFactors. 2026. doi:10.1002/biof.70135

BibTeX
@article{Xu2026,
  author = {Xu, Xue and Yang, Ruxue and Fang, Lutong and Sun, Min and Ma, Ying and Zhang, Ying and Wu, Chenxin},
  title = {A Multi‐Omics and Single‐Cell Framework Identifies ITGA1 as a Candidate Predictive Biomarker of Neoadjuvant Chemotherapy Response in Epithelial Ovarian Cancer},
  journal = {BioFactors},
  year = {2026},
  doi = {10.1002/biof.70135}
}
Kostenlos starten →